Pricing Log in Create free account

Sionna Therapeutics, Inc. (SION) vs Entrada Therapeutics, Inc. (TRDA)

Sionna Therapeutics, Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Sionna Therapeutics, Inc. and Entrada Therapeutics, Inc. are of similar size ($186.1M and $184.5M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −3,537.7%) and the higher return on invested capital (−125.0% vs −1,060.2%). Across the 13 metrics below, Sionna Therapeutics, Inc. leads on 11 and Entrada Therapeutics, Inc. on 2.

Valuation

Metric SION TRDA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 39.28 9.71
P/B 0.66 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.32 0.22 0.64
EV/Sales n/m (8.31) 9.21
Earnings yield (56.04%) (90.83%) (33.15%)
Free cash flow yield (43.44%) (72.98%) (25.50%)

Profitability

Metric SION TRDA Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (3,767.07%) 0.00%
Net margin 0.00% (3,537.73%) 0.00%
Free cash flow margin 0.00% (2,867.07%) 0.00%
Return on equity (32.34%) (54.09%) (56.36%)
Return on assets (30.66%) (44.35%) (48.04%)
Return on invested capital (125.00%) (1,060.24%) 0.00%

Growth

Metric SION TRDA Biotechnology median
Revenue growth (TTM) — (94.10%) 6.02%
EPS growth (last fiscal year) 88.24% (306.55%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SION TRDA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.05 10.89 4.72
Net debt to EBITDA 2.58 1.88 0.96

Dividend

Metric SION TRDA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SION TRDA Biotechnology median
Market cap 184.47m 186.12m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack